DE3750176D1 - Impfstoff und verfahren zur herstellung. - Google Patents

Impfstoff und verfahren zur herstellung.

Info

Publication number
DE3750176D1
DE3750176D1 DE3750176T DE3750176T DE3750176D1 DE 3750176 D1 DE3750176 D1 DE 3750176D1 DE 3750176 T DE3750176 T DE 3750176T DE 3750176 T DE3750176 T DE 3750176T DE 3750176 D1 DE3750176 D1 DE 3750176D1
Authority
DE
Germany
Prior art keywords
vaccine
production method
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE3750176T
Other languages
English (en)
Other versions
DE3750176T2 (de
Inventor
Robert Hunter
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Emory University
Original Assignee
Emory University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Emory University filed Critical Emory University
Application granted granted Critical
Publication of DE3750176D1 publication Critical patent/DE3750176D1/de
Publication of DE3750176T2 publication Critical patent/DE3750176T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
    • A61K2039/6031—Proteins
    • A61K2039/6068—Other bacterial proteins, e.g. OMP
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
DE3750176T 1986-09-22 1987-08-19 Impfstoff und verfahren zur herstellung. Expired - Fee Related DE3750176T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US90996486A 1986-09-22 1986-09-22
US7518787A 1987-07-16 1987-07-16
PCT/US1987/002056 WO1988001873A1 (en) 1986-09-22 1987-08-19 Vaccine and method of preparation

Publications (2)

Publication Number Publication Date
DE3750176D1 true DE3750176D1 (de) 1994-08-11
DE3750176T2 DE3750176T2 (de) 1994-10-13

Family

ID=26756538

Family Applications (1)

Application Number Title Priority Date Filing Date
DE3750176T Expired - Fee Related DE3750176T2 (de) 1986-09-22 1987-08-19 Impfstoff und verfahren zur herstellung.

Country Status (17)

Country Link
EP (1) EP0283505B1 (de)
JP (1) JPH01501064A (de)
KR (1) KR920002165B1 (de)
CN (1) CN1030019A (de)
AP (1) AP8700068A0 (de)
AT (1) ATE108067T1 (de)
BR (1) BR8707471A (de)
CA (1) CA1322721C (de)
DE (1) DE3750176T2 (de)
DK (1) DK272688A (de)
ES (1) ES2007720A6 (de)
FI (1) FI882397A (de)
GR (1) GR871460B (de)
IL (1) IL83953A (de)
NZ (2) NZ236829A (de)
PT (1) PT85760B (de)
WO (1) WO1988001873A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0513861B1 (de) * 1987-11-03 1997-02-26 Syntex (U.S.A.) Inc. Einen Tetra-Polyol enthaltendes Impfstoff-Adjuvans
US6153193A (en) * 1993-04-28 2000-11-28 Supratek Pharma Inc. Compositions for targeting biological agents
US6277410B1 (en) * 1992-10-08 2001-08-21 Supratek Pharma Inc. Copolymer compositions for oral delivery
US6093391A (en) * 1992-10-08 2000-07-25 Supratek Pharma, Inc. Peptide copolymer compositions
US6353055B1 (en) 1994-11-18 2002-03-05 Supratek Pharma Inc. Polynucleotide compositions
US6221959B1 (en) 1994-11-18 2001-04-24 Supratek Pharma, Inc. Polynucleotide compositions
AU2001252458A1 (en) 2000-05-05 2001-11-20 Martin Bachmann Molecular antigen arrays and vaccines
KR20020032772A (ko) * 2000-10-27 2002-05-04 김정우 살모넬라균에 대한 난황항체
US7128911B2 (en) 2001-01-19 2006-10-31 Cytos Biotechnology Ag Antigen arrays for treatment of bone disease
US7320793B2 (en) 2001-01-19 2008-01-22 Cytos Biotechnology Ag Molecular antigen array
US7094409B2 (en) 2001-01-19 2006-08-22 Cytos Biotechnology Ag Antigen arrays for treatment of allergic eosinophilic diseases
US7115266B2 (en) 2001-10-05 2006-10-03 Cytos Biotechnology Ag Angiotensin peptide-carrier conjugates and uses thereof
KR100489615B1 (ko) * 2002-01-30 2005-05-17 주식회사 단바이오텍 리스테리아 모노사이토제네스 감염의 예방 및 치료를 위한항체, 이를 포함하는 알 및 이들의 제조방법
CA2489410C (en) 2002-07-17 2015-01-13 Cytos Biotechnology Ag Molecular antigen arrays
IN2008CN05409A (de) 2002-07-18 2015-10-02 Cytos Biotechnology Ag
WO2004016282A1 (en) 2002-07-19 2004-02-26 Cytos Biotechnology Ag Vaccine compositions containing amyloid beta1-6 antigen arrays
US20060257415A1 (en) * 2002-09-03 2006-11-16 Fondation Eurov Acc Adjuvants
GB0424563D0 (en) 2004-11-05 2004-12-08 Novartis Ag Organic compounds
CA2638760A1 (en) 2006-03-07 2007-09-13 Vaxinnate Corporation Compositions that include hemagglutinin, methods of making and methods of use thereof
US8728492B2 (en) * 2008-01-18 2014-05-20 Aeras Global Tb Vaccine Foundation Malaria vaccine compositions and constituents which elicit cell mediated immunity
JP2011519828A (ja) 2008-04-18 2011-07-14 バクシネート コーポレーション フラジェリンの欠失変異体と使用方法
WO2011028875A1 (en) * 2009-09-03 2011-03-10 Wake Forest University Health Sciences Immunogenic conjugates for producing immune responses to drugs of abuse and methods of use
CN101914144B (zh) * 2010-04-30 2013-01-09 浙江大学 金黄色葡萄球菌荚膜多糖和蛋白质偶联物及制备方法和用途
CN102580081B (zh) * 2012-02-22 2014-07-02 中国医学科学院医学生物学研究所 Nad、氢氧化铝复合佐剂及含该复合佐剂的疫苗
US8932598B2 (en) 2012-08-28 2015-01-13 Vaxinnate Corporation Fusion proteins and methods of use

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2979528A (en) * 1953-10-19 1961-04-11 Wyandotte Chemicals Corp Nitrogen-containing polyoxyalkylene detergent compositions
US2674619A (en) * 1953-10-19 1954-04-06 Wyandotte Chemicals Corp Polyoxyalkylene compounds
US3022335A (en) * 1955-03-30 1962-02-20 Wyandotte Chemicals Corp Surface active polyoxyalkylene compounds having a plurality of heteric polyoxypropylene-polyoxyethylene chains
US3036118A (en) * 1957-09-11 1962-05-22 Wyandotte Chemicals Corp Mixtures of novel conjugated polyoxyethylene-polyoxypropylene compounds
EP0006916B1 (de) * 1977-09-28 1981-07-08 National Research Development Corporation MHC-Antigene enthaltende immunologische Präparate und deren Herstellung
JPS56500298A (de) * 1979-03-27 1981-03-12
US4372945A (en) * 1979-11-13 1983-02-08 Likhite Vilas V Antigen compounds
FR2517967A1 (fr) * 1981-12-10 1983-06-17 Air Liquide Procede de production d'un vaccin biochimique contre les fievres a salmonelles
US4711876A (en) * 1985-12-05 1987-12-08 Catapano Salvatore J Process for the treatment and remission of AIDS (acquired immune deficiency syndrome)

Also Published As

Publication number Publication date
NZ221868A (en) 1991-03-26
AP8700068A0 (en) 1989-03-21
EP0283505A4 (de) 1989-11-07
DE3750176T2 (de) 1994-10-13
IL83953A0 (en) 1988-02-29
IL83953A (en) 1992-05-25
AU613588B2 (en) 1991-08-08
WO1988001873A1 (en) 1988-03-24
KR880701560A (ko) 1988-11-03
FI882397A0 (fi) 1988-05-20
KR920002165B1 (ko) 1992-03-19
AU7113191A (en) 1991-07-11
AU629103B2 (en) 1992-09-24
ES2007720A6 (es) 1989-07-01
EP0283505B1 (de) 1994-07-06
CA1322721C (en) 1993-10-05
ATE108067T1 (de) 1994-07-15
NZ236829A (en) 1993-07-27
AU8023287A (en) 1988-04-07
PT85760B (pt) 1990-08-31
DK272688A (da) 1988-07-12
CN1030019A (zh) 1989-01-04
EP0283505A1 (de) 1988-09-28
GR871460B (en) 1988-03-21
BR8707471A (pt) 1988-09-13
JPH01501064A (ja) 1989-04-13
FI882397A (fi) 1988-05-20
PT85760A (en) 1987-10-01
DK272688D0 (da) 1988-05-18

Similar Documents

Publication Publication Date Title
DE3784841D1 (de) Konfektprodukt und verfahren zur herstellung.
DE3750176D1 (de) Impfstoff und verfahren zur herstellung.
DE3888885D1 (de) Halbleiteranordnung und verfahren zur herstellung.
DE3582754D1 (de) Medizinisches werkzeug und verfahren zur herstellung.
DE3766029D1 (de) Verfahren und anlage zur herstellung von diamanten.
DE3784162D1 (de) Funktioneller film und verfahren zur herstellung.
DE3783396D1 (de) Verfahren zur herstellung von bishomo-gamma-linolensaeure und eicosapentaensaeure.
DE3778221D1 (de) Faserverschlingungen und verfahren zur herstellung derselben.
DE3777931D1 (de) Titandioxydsol und verfahren zur seiner herstellung.
DE3674752D1 (de) Alpha, alpha-trehalose-derivat und verfahren zur herstellung davon.
DE3856150D1 (de) Halbleiteranordnung und verfahren zur herstellung
DE3770176D1 (de) Verfahren zur herstellung von modellierten und geformten filtern.
DE3777141D1 (de) Mikrokapseln und verfahren zur herstelllung.
DE3870633D1 (de) Verfahren zur herstellung von butyrolactonen und von butandiolen.
DE3681946D1 (de) Zahnfaeuleschutzpraeparate und verfahren zur herstellung derselben.
ATE41668T1 (de) Verfahren und vorrichtung zur herstellung hochmolekularer polyester.
DE3668765D1 (de) Verfahren zur herstellung von borstenwaren und danach hergestellte borstenwaren.
DE3784518D1 (de) Medizinisches material und verfahren zur herstellung.
DE3762855D1 (de) Verfahren zur herstellung von hydroxyalkylaminen und hydroxyalkylpiperazinen.
DE3776364D1 (de) Dauermagnet und verfahren zur herstellung.
DE3684511D1 (de) Verfahren zur herstellung von l-threonin und l-isoleucin.
DE3684922D1 (de) Verfahren zur herstellung von 2-phenylbenzotriazolen und 2-phenylbenzotriazol-n-oxyden.
DE3787543D1 (de) Verfahren zur herstellung von 6,13-dihydrochinacridonen und chinacridonen.
DE3783199D1 (de) Verfahren zur herstellung von 4,4' diaminodiphenylmethan und derivaten davon.
DE3770224D1 (de) Verfahren zur herstellung von hypofluoriten und bis-hypofluoriten.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee